Programmed anti-inflammatory macrophages protect against AKI and promote repair through trophic actions

Allgren, 1997, Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group, N Engl J Med, 336, 828, 10.1056/NEJM199703203361203 Hirschberg, 1999, Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure, Kidney Int, 55, 2423, 10.1046/j.1523-1755.1999.00463.x Endre, 2011, Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial), Kidney Int, 77, 1020, 10.1038/ki.2010.25 Togel, 2010, Mesenchymal stem cells: a new therapeutic tool for AKI, Nat Rev Nephrol, 6, 179, 10.1038/nrneph.2009.229 Duffield, 2010, Macrophages and kidney disease: macrophages and immunological inflammation of the kidney, Semin Nephrol, 30, 234, 10.1016/j.semnephrol.2010.03.003 Lee, 2011, Distinct macrophage phenotypes contribute to kidney injury and repair, J Am Soc Nephrol, 22, 317, 10.1681/ASN.2009060615 Wilson, 2002, Bone-marrow-derived macrophages genetically modified to produce IL-10 reduce injury in experimental glomerulonephritis, Mol Ther, 6, 710, 10.1006/mthe.2002.0802 Nemeth, 2009, Bone marrow stromal cells attenuate sepsis via prostaglandin E2-dependent reprogramming of host macrophages to increase their interleukin-10 production, Nat Med, 15, 42, 10.1038/nm.1905 Togel, 2005, Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms, Am J Physiol Renal Physiol, 289, F31, 10.1152/ajprenal.00007.2005 Jung, 2012, Infusion of IL-10–expressing cells protects against renal ischemia through induction of lipocalin-2, Kidney Int, 81, 969, 10.1038/ki.2011.446 Lee, 2002, Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice, Nat Med, 8, 240, 10.1038/nm0302-240